These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28971530)

  • 1. Dominant high expression of wild-type HSP110 defines a poor prognostic subgroup of colorectal carcinomas with microsatellite instability: a whole-section immunohistochemical analysis.
    Oh HJ; Kim JH; Lee TH; Park HE; Bae JM; Lee HS; Kang GH
    APMIS; 2017 Dec; 125(12):1076-1083. PubMed ID: 28971530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion in HSP110 T
    Kim KJ; Lee TH; Kim JH; Cho NY; Kim WH; Kang GH
    Hum Pathol; 2017 Sep; 67():109-118. PubMed ID: 28811251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression status of wild-type HSP110 correlates with HSP110 T17 deletion size and patient prognosis in microsatellite-unstable colorectal cancer.
    Kim JH; Kim KJ; Rhee YY; Oh S; Cho NY; Lee HS; Kang GH
    Mod Pathol; 2014 Mar; 27(3):443-53. PubMed ID: 24030751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with colorectal tumors with microsatellite instability and large deletions in HSP110 T17 have improved response to 5-fluorouracil–based chemotherapy.
    Collura A; Lagrange A; Svrcek M; Marisa L; Buhard O; Guilloux A; Wanherdrick K; Dorard C; Taieb A; Saget A; Loh M; Soong R; Zeps N; Platell C; Mews A; Iacopetta B; De Thonel A; Seigneuric R; Marcion G; Chapusot C; Lepage C; Bouvier AM; Gaub MP; Milano G; Selves J; Senet P; Delarue P; Arzouk H; Lacoste C; Coquelle A; Bengrine-Lefèvre L; Tournigand C; Lefèvre JH; Parc Y; Biard DS; Fléjou JF; Garrido C; Duval A
    Gastroenterology; 2014 Feb; 146(2):401-11.e1. PubMed ID: 24512910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer.
    Kim JH; Rhee YY; Bae JM; Cho NY; Kang GH
    Am J Surg Pathol; 2013 Oct; 37(10):1532-41. PubMed ID: 24025523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite instability test using peptide nucleic acid probe-mediated melting point analysis: a comparison study.
    Jang M; Kwon Y; Kim H; Kim H; Min BS; Park Y; Kim TI; Hong SP; Kim WK
    BMC Cancer; 2018 Dec; 18(1):1218. PubMed ID: 30514259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major improvement in the detection of microsatellite instability in colorectal cancer using HSP110 T17 E-ice-COLD-PCR.
    How-Kit A; Daunay A; Buhard O; Meiller C; Sahbatou M; Collura A; Duval A; Deleuze JF
    Hum Mutat; 2018 Mar; 39(3):441-453. PubMed ID: 29227006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference between proximal and distal microsatellite-unstable sporadic colorectal cancers: analysis of clinicopathological and molecular features and prognoses.
    Kim YH; Min BH; Kim SJ; Choi HK; Kim KM; Chun HK; Lee H; Kim JY; Chang DK; Son HJ; Rhee PL; Rhee JC; Kim JJ
    Ann Surg Oncol; 2010 May; 17(5):1435-41. PubMed ID: 20049642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability.
    Korehisa S; Oki E; Iimori M; Nakaji Y; Shimokawa M; Saeki H; Okano S; Oda Y; Maehara Y
    Int J Cancer; 2018 Feb; 142(4):822-832. PubMed ID: 29044503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implication of CD274 (PD-L1) protein expression in tumor-infiltrating immune cells for microsatellite unstable and stable colorectal cancer.
    Lee KS; Kwak Y; Ahn S; Shin E; Oh HK; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
    Cancer Immunol Immunother; 2017 Jul; 66(7):927-939. PubMed ID: 28405764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSP110 as a Diagnostic but Not a Prognostic Biomarker in Colorectal Cancer With Microsatellite Instability.
    Tachon G; Chong-Si-Tsaon A; Lecomte T; Junca A; Frouin É; Miquelestorena-Standley E; Godet J; Evrard C; Randrian V; Chautard R; Auriault ML; Moulin V; Guyetant S; Fromont G; Karayan-Tapon L; Tougeron D
    Front Genet; 2021; 12():769281. PubMed ID: 35047001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability.
    Kim JH; Rhee YY; Kim KJ; Cho NY; Lee HS; Kang GH
    APMIS; 2014 Dec; 122(12):1187-95. PubMed ID: 24909058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSP110 T17 simplifies and improves the microsatellite instability testing in patients with colorectal cancer.
    Buhard O; Lagrange A; Guilloux A; Colas C; Chouchène M; Wanherdrick K; Coulet F; Guillerm E; Dorard C; Marisa L; Bokhari A; Greene M; El-Murr N; Bodo S; Muleris M; Sourouille I; Svrcek M; Cervera P; Blanché H; Lefevre JH; Parc Y; Lepage C; Chapusot C; Bouvier AM; Gaub MP; Selves J; Garrett K; Iacopetta B; Soong R; Hamelin R; Garrido C; Lascols O; André T; Fléjou JF; Collura A; Duval A
    J Med Genet; 2016 Jun; 53(6):377-84. PubMed ID: 26831756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite instability affecting the T17 repeats in intron 8 of HSP110, as well as five mononucleotide repeats in patients with colorectal carcinoma.
    Markovic S; Antic J; Dimitrijevic I; Zogovic B; Bojic D; Svorcan P; Markovic V; Krivokapic Z
    Biomark Med; 2013 Aug; 7(4):613-21. PubMed ID: 23905898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases.
    Buckowitz A; Knaebel HP; Benner A; Bläker H; Gebert J; Kienle P; von Knebel Doeberitz M; Kloor M
    Br J Cancer; 2005 May; 92(9):1746-53. PubMed ID: 15856045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis.
    Dorard C; de Thonel A; Collura A; Marisa L; Svrcek M; Lagrange A; Jego G; Wanherdrick K; Joly AL; Buhard O; Gobbo J; Penard-Lacronique V; Zouali H; Tubacher E; Kirzin S; Selves J; Milano G; Etienne-Grimaldi MC; Bengrine-Lefèvre L; Louvet C; Tournigand C; Lefèvre JH; Parc Y; Tiret E; Fléjou JF; Gaub MP; Garrido C; Duval A
    Nat Med; 2011 Sep; 17(10):1283-9. PubMed ID: 21946539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between microsatellite instability and hepatocyte growth factor expression and their prognostic significance in colorectal cancer].
    Yang G; Zheng HX; Wu LN; Wan HL; Li N; Yang GC; Liang JF
    Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):283-8. PubMed ID: 27087375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer.
    Kim JH; Cho NY; Bae JM; Kim KJ; Rhee YY; Lee HS; Kang GH
    Int J Clin Exp Pathol; 2015; 8(2):1920-8. PubMed ID: 25973084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
    Marginean EC; Melosky B
    Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of patients with microsatellite-unstable colorectal carcinomas depend on L1 methylation level.
    Rhee YY; Kim MJ; Bae JM; Koh JM; Cho NY; Juhnn YS; Kim D; Kang GH
    Ann Surg Oncol; 2012 Oct; 19(11):3441-8. PubMed ID: 22618722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.